Combination Effects of High-dose Statin and Trimetazidine on Patients With Aspirin Mono Antiplatelet Therapy 12-months After Coronary Artery Bypass Surgery

NCT01857921 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

290

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery

Interventions

DRUG: Pravastatin 20mg/day for 12 months after randomization
DRUG: Atorvastatin 40 mg and trimetazidine MR 70 mg/day for 12 months after randomization

Sponsor

Yonsei University